Organic electroluminescent materials and devices

Information

  • Patent Grant
  • 11917902
  • Patent Number
    11,917,902
  • Date Filed
    Friday, June 28, 2019
    5 years ago
  • Date Issued
    Tuesday, February 27, 2024
    8 months ago
Abstract
Novel organometallic complexes having a structure of Formula (I)
Description
FIELD OF THE INVENTION

The present invention relates to organic light emitting devices (OLEDs). In particular, the invention relates to metal complexes having a bridged N,N-diaryl ligand and their use in various devices, including OLEDs.


BACKGROUND

Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.


OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.


One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Color may be measured using CIE coordinates, which are well known to the art.


One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy)3, which has the following structure:




embedded image


In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.


As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.


As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.


As used herein, “solution processible” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.


A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.


As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.


As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.


More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.


SUMMARY OF THE INVENTION

In at least one aspect, the invention provides metal complexes having an N,N-diaryl ligand, such as compounds having Formula (I):




embedded image



wherein each Lx is independently a monodentate ligand, and any two adjacent Lx may optionally combine to form a bidentate ligand; wherein M1 is cobalt(I), rhodium(I), iridium(I), nickel(II), platinum(II), palladium(II), silver(III), gold(III), or copper(III); wherein m is a value from 1 to the maximum number of ligands that may be attached to M1; wherein m+n is the maximum number of ligands that may be attached to M1; wherein G1 is O or CR4R5; wherein R1 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R2 represents mono-, di-, or tri-substitution, wherein each R2 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R2 may optionally combine to form a ring, which can be further substituted; wherein R3 represents mono-, di-, tri-, or tetra-substitution, wherein each R3 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R3 may optionally combine to form a ring, which can be further substituted; wherein R4 and R5 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R4 and R5 may optionally combine to form a ring, which can be further substituted; wherein R1 may optionally combine with any R3 to form a ring system, which can be further substituted; wherein any of R4 or R5 may optionally combine with any R2 or R3 to form a ring system, which can be further substituted; and wherein any of R1, R2, or R3 may optionally combine with one or more Lx to form a bidentate, tridentate, or tetradentate ligand.


In some embodiments, M1 is platinum(II), palladium(II), or gold(III). In some other embodiments, M1 is platinum (II).


In some embodiments, G1 is O, C(CH3)2, or C(C6H5)2.


In some embodiments, the metal complex is a compound having Formula (II):




embedded image



wherein rings A1, A2, and A3 are independently five- or six-membered carbocyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; Z1 and Z2 are independently carbon or nitrogen; wherein R2 represents mono- or di-substitution, wherein each R2 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R2 may optionally combine to form a ring, which can be further substituted; wherein R3 represents mono-, di-, tri-, or tetra-substitution, wherein each R3 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R3 may optionally combine to form a ring, which can be further substituted; wherein R6 represents mono-, di-, or tri-substitution, wherein each R6 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R6 may optionally combine to form a ring, which can be further substituted; wherein R7 and R8 represent mono-, di-, tri-, or tetra-substitution, wherein each R7 or R8 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R7 or any two adjacent R8 may optionally combine to form a ring, which can be further substituted; wherein any R3 may optionally combine with any R6 to form a ring system, which can be further substituted; wherein any R2 may optionally combine with any R8 to form a ring system, which can be further substituted; and wherein any R6 may optionally combine with any R7 to form a ring system, which can be further substituted; wherein any R7 may optionally combine with any R8 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some such embodiments, the metal complex is a compound having Formula (IIa):




embedded image


In some other such embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (IV):




embedded image



wherein rings A4, A5, and A6 are independently five- or six-membered carbocyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; wherein Z3, Z4, and Z5 are independently carbon or nitrogen; wherein G2 is oxygen, sulfur, CR12R12a, SiR12R12a, or NR12; wherein each R12 and R12a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R12 and R12a may optionally combine with each other or with any one R10 or R11 to form a ring system, which can be further substituted; wherein R9 and R10 represent mono-, di-, tri-, or tetra-substitution, wherein each R9 or R10 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R9 or any two adjacent R10 may optionally combine to form a ring, which can be further substituted; wherein R11 represents mono-, di-, or tri-substitution, wherein each R11 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R11 may optionally combine to form a ring, which can be further substituted; wherein any R3 may optionally combine with any R11 to form a ring system, which can be further substituted; and wherein any R2 may optionally combine with any R9 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some such embodiments, the metal complex is a compound having Formula (IVa):




embedded image


In some embodiments where the metal complex has a Formula (IV) or Formula (IVa), G2 is NR12, and R12 is phenyl.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (V):




embedded image



wherein rings A7, A8, and A9 are independently five- or six-membered carbocyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; wherein Z6 and Z7 independently are carbon or nitrogen; G3 is oxygen, sulfur, CR16R16a, SiR16R16a, or NR16; wherein each R16 and R16a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R16 and R16a may optionally combine with each other or with any one R13 or R14 to form a ring system, which can be further substituted; wherein R13 and R14 represent mono-, di-, or tri-substitution, wherein each R13 or R14 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R13 or any two adjacent R14 may optionally combine to form a ring, which can be further substituted; wherein R15 represents mono-, di-, tri- or tetra-substitution, wherein each R15 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R15 may optionally combine to form a ring, which can be further substituted; wherein any R2 may optionally combine with any R13 to form a ring system, which can be further substituted; and wherein any R14 may optionally combine with any R15 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some such embodiments, the metal complex is a compound having Formula (Va):




embedded image


In some embodiments where the metal complex has a Formula (V) or Formula (Va), G3 is NR16, and R16 is phenyl.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (VI):




embedded image



wherein rings A7, A8, and A9 are independently five- or six-membered carbocyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; wherein Z8 and Z9 are independently carbon or nitrogen; wherein G4 is oxygen, sulfur, CR20R20a, SiR20R20a, or NR20; wherein each R20 and R20a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R20 and R20a may optionally combine with each other or with any one R18 or R19 to form a ring system, which can be further substituted; wherein G5 is oxygen, sulfur, CR21R21a, SiR21R21a, or NR21; wherein each R21 and R21a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R21 and R21a may optionally combine with each other or with any one R2 or R17 to form a ring system, which can be further substituted; wherein R17 and R18 represent mono-, di-, tri-, or tetra-substitution, wherein each R17 or R18 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R17 or any two adjacent R18 may optionally combine to form a ring, which can be further substituted; wherein R19 represents mono-, di-, or tri-substitution, wherein each R19 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R19 may optionally combine to form a ring, which can be further substituted; wherein any R3 may optionally combine with any R19 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (VII):




embedded image



wherein each Ly is independently a monodentate ligand, and any two adjacent Ly may optionally combine to form a bidentate ligand; wherein M2 is cobalt(I), rhodium(I), iridium(I), nickel(II), platinum(II), palladium(II), silver(III), gold(III), or copper(III); wherein p is a value from 1 to the maximum number of ligands that may be attached to M2; wherein p+q is the maximum number of ligands that may be attached to M2; wherein G6 is O or CR24R25; wherein R21 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R22 represents mono-, di-, or tri-substitution, wherein each R22 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R2 may optionally combine to form a ring, which can be further substituted; wherein R23 represents mono-, di-, tri-, or tetra-substitution, wherein each R23 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R3 may optionally combine to form a ring, which can be further substituted; wherein R24 and R25 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R24 and R25 may optionally combine to form a ring, which can be further substituted; wherein R21 may optionally combine with any R23 to form a ring system, which can be further substituted; wherein any of R24 or R25 may optionally combine with any R22 or R23 to form a ring system, which can be further substituted; and wherein any of R21, R22, or R23 may optionally combine with one or more Ly to form a bidentate, tridentate, or tetradentate ligand.


In some embodiments, M2 is platinum(II), palladium(II), or gold(III). In some other embodiments, M2 is platinum (II).


In some embodiments, G6 is O, C(CH3)2, or C(C6H5)2.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


embedded image


In another aspect, the invention provides devices that include metal complexes having a bridged N,N-diaryl ligand, such as those described in the foregoing paragraphs. In some embodiments, the invention provides a first device comprising a first organic light emitting device, which further comprises: an anode; a cathode; and an organic layer disposed between the anode and the cathode, which comprises a boron-nitrogen heterocycle according to any of the above embodiments. In some embodiments, the first device is a consumer product. In some embodiments, the first device is an organic light emitting device (OLED). In some embodiments, the first device comprises a lighting panel.


In some embodiments, the organic layer of the first device is an emissive layer. In some such embodiments, the emissive layer comprises an emissive dopant. In some embodiments, a metal complex having a bridged N,N-diaryl ligand (as described above) is an emissive dopant. In some other embodiments, a metal complex having a bridged N,N-diaryl ligand (as described above) is a non-emissive dopant.


In some embodiments, the organic layer of the first device comprises a host. In some such embodiments, the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan; wherein any substituent in the host is an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡C—CnH2n+1, Ar1, Ar1—Ar2, and CnH2n—Ar1, or the host has; wherein n is from 1 to 10; and wherein Art and Ar2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. In some other embodiments, the host comprises a compound selected from the group consisting of: carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.


In some embodiments, the host is a compound selected from the group consisting of:




embedded image


embedded image



and combinations thereof.


In some embodiments, the host is a metal complex.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows an organic light emitting device.



FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.



FIG. 3 shows an embodiment of a metal complex having a bridged N,N-diaryl ligand.



FIG. 4 shows a positive-mode MALDI-TOF mass spectrum for Host 1 and Comparative Example 3. The arrow shows the major fragment, which is the loss of N-phenyl. The inset shows the structure and mass of the bond-broken photoproduct.



FIG. 5 shows a positive-mode MALDI-TOF mass spectrum for Host 1 and Comparative Example 2. The arrow shows the major fragment, which is the loss of N-phenyl. The inset shows the structure and mass of the bond-broken photoproduct.



FIG. 6 shows a positive-mode MALDI-TOF mass spectrum for Host 1 and Comparative Example 1. The arrow shows the major fragment, which is the loss of N-phenyl. The inset shows the structure and mass of the bond-broken photoproduct.



FIG. 7 shows the geometry for Compound 3, which shows the N-phenyl bond intact. The left structure shows the optimized ground state triplet. The right structure shows an optimized N-phenyl bond-breaking triplet. Slight differences in the geometry of the phenyl and germinal dimethyl groups can be seen, which may account for the small calculated energy difference of 5.22 kcal/mol.





DETAILED DESCRIPTION

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.


The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.


More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), which are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.



FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.


More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F.sub.4-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.



FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.


The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2.


Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.


Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. patent application Ser. No. 10/233,470, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink-jet and OVJD. Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processibility than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.


Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.


Devices fabricated in accordance with embodiments of the invention may be incorporated into a wide variety of consumer products, including flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads up displays, fully transparent displays, flexible displays, laser printers, telephones, cell phones, personal digital assistants (PDAs), laptop computers, digital cameras, camcorders, viewfinders, micro-displays, vehicles, a large area wall, theater or stadium screen, or a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.).


The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.


The terms halo, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, arylkyl, heterocyclic group, aryl, aromatic group, and heteroaryl are known to the art, and are defined in U.S. Pat. No. 7,279,704 at cols. 31-32, which are incorporated herein by reference.


Metal complexes having ligands with N,N-diaryl groups can function as emissive agents, e.g., phosphorescent emitters. In some instances, however, such structures may exhibit instability due to rupture of the N-aryl bond, thereby limiting the utility of such compounds as emissive agents. In some embodiments of the invention, a bridging group is incorporated into the N,N-diaryl ligand structure to stabilize the ligand and strengthen the N-aryl bond. The disclosed bridging structures can also improve the steric properties of the ligand and make it more suitable for certain types of coordination, such as tetradentate coordination in a square planar configuration (e.g., with platinum (II)).


In at least one aspect, the invention provides metal complexes having an N,N-diaryl ligand, such as compounds having Formula (I):




embedded image



wherein each Lx is independently a monodentate ligand, and any two adjacent Lx may optionally combine to form a bidentate ligand; wherein M1 is cobalt(I), rhodium(I), iridium(I), nickel(II), platinum(II), palladium(II), silver(III), gold(III), or copper(III); wherein m is a value from 1 to the maximum number of ligands that may be attached to M1; wherein m+n is the maximum number of ligands that may be attached to M1; wherein G1 is O or CR4R5; wherein R1 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R2 represents mono-, di-, or tri-substitution, wherein each R2 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R2 may optionally combine to form a ring, which can be further substituted; wherein R3 represents mono-, di-, tri-, or tetra-substitution, wherein each R3 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R3 may optionally combine to form a ring, which can be further substituted; wherein R4 and R5 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R4 and R5 may optionally combine to form a ring, which can be further substituted; wherein R1 may optionally combine with any R3 to form a ring system, which can be further substituted; wherein any of R4 or R5 may optionally combine with any R2 or R3 to form a ring system, which can be further substituted; and wherein any of R1, R2, or R3 may optionally combine with one or more Lx to form a bidentate, tridentate, or tetradentate ligand.


In some embodiments, M1 is platinum(II), palladium(II), or gold(III). In some other embodiments, M1 is platinum (II).


In some embodiments, G1 is O, C(CH3)2, or C(C6H5)2.


In some embodiments, the metal complex is a compound having Formula (II):




embedded image



wherein rings A1, A2, and A3 are independently five- or six-membered carbocyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; Z1 and Z2 are independently carbon or nitrogen; wherein R2 represents mono- or di-substitution, wherein each R2 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R2 may optionally combine to form a ring, which can be further substituted; wherein R3 represents mono-, di-, tri-, or tetra-substitution, wherein each R3 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R3 may optionally combine to form a ring, which can be further substituted; wherein R6 represents mono-, di-, or tri-substitution, wherein each R6 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R6 may optionally combine to form a ring, which can be further substituted; wherein R7 and R8 represent mono-, di-, tri-, or tetra-substitution, wherein each R7 or R8 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R7 or any two adjacent R8 may optionally combine to form a ring, which can be further substituted; wherein any R3 may optionally combine with any R6 to form a ring system, which can be further substituted; wherein any R2 may optionally combine with any R8 to form a ring system, which can be further substituted; and wherein any R6 may optionally combine with any R7 to form a ring system, which can be further substituted; wherein any R7 may optionally combine with any R8 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some such embodiments, the metal complex is a compound having Formula (IIa):




embedded image


In some other such embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (IV):




embedded image



wherein rings A4, A5, and A6 are independently five- or six-membered carbocyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; wherein Z3, Z4, and Z5 are independently carbon or nitrogen; wherein G2 is oxygen, sulfur, CR12R12a, SiR12R12a, or NR12 wherein each R12 and R12a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R12 and R12a may optionally combine with each other or with any one R10 or R11 to form a ring system, which can be further substituted; wherein R9 and R10 represent mono-, di-, tri-, or tetra-substitution, wherein each R9 or R10 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R9 or any two adjacent R10 may optionally combine to form a ring, which can be further substituted; wherein R11 represents mono-, di-, or tri-substitution, wherein each R11 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R11 may optionally combine to form a ring, which can be further substituted; wherein any R3 may optionally combine with any R11 to form a ring system, which can be further substituted; and wherein any R2 may optionally combine with any R9 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some such embodiments, the metal complex is a compound having Formula (IVa):




embedded image


In some embodiments where the metal complex has a Formula (IV) or Formula (IVa), G2 is NR12, and R12 is phenyl.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (V):




embedded image



wherein rings A7, A8, and A9 are independently five- or six-membered carboyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; wherein Z6 and Z7 independently are carbon or nitrogen; G3 is oxygen, sulfur, CR16R16a, SiR16R16a, or NR16; wherein each R16 and R16a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R16 and R16a may optionally combine with each other or with any one R13 or R14 to form a ring system, which can be further substituted; wherein R13 and R14 represent mono-, di-, or tri-substitution, wherein each R13 or R14 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R13 or any two adjacent R14 may optionally combine to form a ring, which can be further substituted; wherein R15 represents mono-, di-, tri- or tetra-substitution, wherein each R15 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R15 may optionally combine to form a ring, which can be further substituted; wherein any R2 may optionally combine with any R13 to form a ring system, which can be further substituted; and wherein any R14 may optionally combine with any R15 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some such embodiments, the metal complex is a compound having Formula (Va):




embedded image


In some embodiments where the metal complex has a Formula (V) or Formula (Va), G3 is NR16, and R16 is phenyl.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (VI):




embedded image



wherein rings A7, A8, and A9 are independently five- or six-membered carbocyclic or heterocyclic aromatic rings having 0-3 nitrogen atoms and 0-1 additional heteroatoms selected from the group consisting of oxygen, sulfur, and selenium; wherein Z8 and Z9 are independently carbon or nitrogen; wherein G4 is oxygen, sulfur, CR20R20a, SiR20R20a, or NR20; wherein each R20 and R20a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R20 and R20a may optionally combine with each other or with any one R18 or R19 to form a ring system, which can be further substituted; wherein G5 is oxygen, sulfur, CR21R21a, SiR21R21a, or NR21; wherein each R21 and R21a is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R21 and R21a may optionally combine with each other or with any one R2 or R17 to form a ring system, which can be further substituted; wherein R17 and R18 represent mono-, di-, tri-, or tetra-substitution, wherein each R17 or R18 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R17 or any two adjacent R18 may optionally combine to form a ring, which can be further substituted; wherein R19 represents mono-, di-, or tri-substitution, wherein each R19 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R19 may optionally combine to form a ring, which can be further substituted; wherein any R3 may optionally combine with any R19 to form a ring system, which can be further substituted. The other variables have the definitions provided in the above embodiments.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


In some embodiments, the metal complex is a compound having Formula (VII):




embedded image



wherein each Ly is independently a monodentate ligand, and any two adjacent Ly may optionally combine to form a bidentate ligand; wherein M2 is cobalt(I), rhodium(I), iridium(I), nickel(II), platinum(II), palladium(II), silver(III), gold(III), or copper(III); wherein p is a value from 1 to the maximum number of ligands that may be attached to M2; wherein p+q is the maximum number of ligands that may be attached to M2; wherein G6 is O or CR24R25; wherein R21 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R22 represents mono-, di-, or tri-substitution, wherein each R22 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R2 may optionally combine to form a ring, which can be further substituted; wherein R23 represents mono-, di-, tri-, or tetra-substitution, wherein each R23 is selected independently from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein any two adjacent R3 may optionally combine to form a ring, which can be further substituted; wherein R24 and R25 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and wherein R24 and R25 may optionally combine to form a ring, which can be further substituted; wherein R21 may optionally combine with any R23 to form a ring system, which can be further substituted; wherein any of R24 or R25 may optionally combine with any R22 or R23 to form a ring system, which can be further substituted; and wherein any of R21, R22, or R23 may optionally combine with one or more Ly to form a bidentate, tridentate, or tetradentate ligand.


In some embodiments, M2 is platinum(II), palladium(II), or gold(III). In some other embodiments, M2 is platinum (II).


In some embodiments, G6 is O, C(CH3)2, or C(C6H5)2.


In some other embodiments, the metal complex is a compound selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


embedded image


In another aspect, the invention provides devices that include metal complexes having a bridged N,N-diaryl ligand, such as those described in the foregoing paragraphs. In some embodiments, the invention provides a first device comprising a first organic light emitting device, which further comprises: an anode; a cathode; and an organic layer disposed between the anode and the cathode, which comprises a boron-nitrogen heterocycle according to any of the above embodiments. In some embodiments, the first device is a consumer product. In some embodiments, the first device is an organic light emitting device (OLED). In some embodiments, the first device comprises a lighting panel.


In some embodiments, the organic layer of the first device is an emissive layer. In some such embodiments, the emissive layer comprises an emissive dopant. In some embodiments, a metal complex having a bridged N,N-diaryl ligand (as described above) is an emissive dopant. In some other embodiments, a metal complex having a bridged N,N-diaryl ligand (as described above) is a non-emissive dopant.


In some embodiments, the organic layer of the first device comprises a host. In some such embodiments, the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan; wherein any substituent in the host is an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡C—CnH2n+1, Ar1, Ar1—Ar2, and CnH2n—Ar1, or the host has; wherein n is from 1 to 10; and wherein Ar1 and Ar2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. In some other embodiments, the host comprises a compound selected from the group consisting of: carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.


In some embodiments, the host is a compound selected from the group consisting of:




embedded image


embedded image



and combinations thereof.


In some embodiments, the host is a metal complex.


Combination with Other Materials


The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.


HIL/HTL:


A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but not limit to: a phthalocyanine or porphryin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and sliane derivatives; a metal oxide derivative, such as MoOx; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.


Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:




embedded image


Each of Ar1 to Ar9 is selected from the group consisting aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, azulene; group consisting aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and group consisting 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Wherein each Ar is further substituted by a substituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.


In one aspect, Ar1 to Ar9 is independently selected from the group consisting of:




embedded image


k is an integer from 1 to 20; X101 to X108 is C (including CH) or N; Z101 is NAr1, O, or S; Ar1 has the same group defined above.


Examples of metal complexes used in HIL or HTL include, but not limit to the following general formula:




embedded image


Met is a metal; (Y101-Y102) is a bidentate ligand, Y101 and Y102 are independently selected from C, N, O, P, and S; L101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.


In one aspect, (Y101-Y102) is a 2-phenylpyridine derivative.


In another aspect, (Y101-Y102) is a carbene ligand.


In another aspect, Met is selected from Ir, Pt, Os, and Zn.


In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc+/Fc couple less than about 0.6 V.


Host:


The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. While the Table below categorizes host materials as preferred for devices that emit various colors, any host material may be used with any dopant so long as the triplet criteria is satisfied.


Examples of metal complexes used as host are preferred to have the following general formula:




embedded image


Met is a metal; (Y103-Y104) is a bidentate ligand, Y103 and Y104 are independently selected from C, N, O, P, and S; L101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.


In one aspect, the metal complexes are:




embedded image


(O—N) is a bidentate ligand, having metal coordinated to atoms O and N.


In another aspect, Met is selected from Ir and Pt.


In a further aspect, (Y103-Y104) is a carbene ligand.


Examples of organic compounds used as host are selected from the group consisting aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, azulene; group consisting aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and group consisting 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atome, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Wherein each group is further substituted by a substituent selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.


In one aspect, host compound contains at least one of the following groups in the molecule:




embedded image


embedded image


R101 to R107 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above.


k is an integer from 1 to 20; k′″ is an integer from 0 to 20.


X101 to X108 is selected from C (including CH) or N.


Z101 and Z102 is selected from NR101, O, or S.


HBL:


A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED.


In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.


In another aspect, compound used in HBL contains at least one of the following groups in the molecule:




embedded image


k is an integer from 1 to 20; L101 is another ligand, k′ is an integer from 1 to 3.


ETL:


Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.


In one aspect, compound used in ETL contains at least one of the following groups in the molecule:




embedded image


R101 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above.


Ar1 to Ar3 has the similar definition as Ar's mentioned above.


k is an integer from 1 to 20.


X101 to X108 is selected from C (including CH) or N.


In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:




embedded image


(O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.


In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. encompasses undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also encompass undeuterated, partially deuterated, and fully deuterated versions thereof.


In addition to and/or in combination with the materials disclosed herein, many hole injection materials, hole transporting materials, host materials, dopant materials, exiton/hole blocking layer materials, electron transporting and electron injecting materials may be used in an OLED. Non-limiting examples of the materials that may be used in an OLED in combination with materials disclosed herein are listed in Table 1 below. Table 1 lists non-limiting classes of materials, non-limiting examples of compounds for each class, and references that disclose the materials.











TABLE 1





MATERIAL
EXAMPLES OF MATERIAL
PUBLICATIONS















Hole injection materials









Phthalocyanine and porphryin compounds


embedded image


Appl. Phys. Lett. 69, 2160 (1996)





Starburst triarylamines


embedded image


J. Lumin. 72-74, 985 (1997)





CFx Fluorohydrocarbon polymer


embedded image


Appl. Phys. Lett. 78, 673 (2001)





Conducting polymers (e.g., PEDOT:PSS, polyaniline, polypthiophene)


embedded image


Synth. Met. 87, 171 (19997) WO2007002683





Phosphonic acid and sliane SAMs


embedded image


US20030162053





Triarylamine or polythiophene polymers with conductivity dopants


embedded image


EP1725079A1








embedded image








Organic compounds with conductive inorganic compounds, such as molybdenum and tungsten oxides


embedded image


US20050123751 SID Symposium Digest, 37, 923 (2006) WO2009018009





n-type semiconducting organic complexes


embedded image


US20020158242





Metal organometallic complexes


embedded image


US20060240279





Cross-linkable compounds


embedded image


US20080220265





Polythiophene based polymers and copolymers


embedded image


WO 2011075644 EP2350216










Hole transporting materials









Triarylamines (e.g., TPD, α-NPD)


embedded image


Appl. Phys. Lett. 51, 913 (1987)








embedded image


U.S. Pat. No. 5,061,569








embedded image


EP650955








embedded image


J. Mater. Chem. 3, 319 (1993)








embedded image


Appl. Phys. Lett. 90, 183503 (2007)








embedded image


Appl. Phys. Lett. 90, 183503 (2007)





Triaylamine on spirofluorene core


embedded image


Synth. Met. 91, 209 (1997)





Arylamine carbazole compounds


embedded image


Adv. Mater. 6, 677 (1994), US20080124572





Triarylamine with (di)benzothiophene/(di) benzofuran


embedded image


US20070278938, US20080106190 US20110163302





Indolocarbazoles


embedded image


Synth. Met. 111, 421 (2000)





Isoindole compounds


embedded image


Chem. Mater. 15, 3148 (2003)





Metal carbene complexes


embedded image


US20080018221










Phosphorescent OLED host materials


Red hosts









Arylcarbazoles


embedded image


Appl. Phys. Lett. 78, 1622 (2001)





Metal 8-hydroxyquinolates (e.g., Alq3, BAlq)


embedded image


Nature 395, 151 (1998)








embedded image


US20060202194








embedded image


WO2005014551








embedded image


WO2006072002





Metal phenoxybenzothiazole compounds


embedded image


Appl. Phys. Lett. 90, 123509 (2007)





Conjugated oligomers and polymers (e.g., polyfluorene)


embedded image


Org. Electron. 1, 15 (2000)





Aromatic fused rings


embedded image


WO2009066779, WO2009066778, WO2009063833, US20090045731, US20090045730, WO2009008311, US20090008605, US20090009065





Zinc complexes


embedded image


WO2010056066





Chrysene based compounds


embedded image


WO2011086863










Green hosts









Arylcarbazoles


embedded image


Appl. Phys. Lett. 78, 1622 (2001)








embedded image


US20030175553








embedded image


WO2001039234





Aryltriphenylene compounds


embedded image


US20060280965








embedded image


US20060280965








embedded image


WO2009021126





Poly-fused heteroaryl compounds


embedded image


US20090309488 US20090302743 US20100012931





Donor acceptor type molecules


embedded image


WO2008056746








embedded image


WO2010107244





Aza-carbazole/DBT/ DBF


embedded image


JP2008074939








embedded image


US20100187984





Polymers (e.g., PVK)


embedded image


Appl. Phys. Lett. 77, 2280 (2000)





Spirofluorene compounds


embedded image


WO2004093207





Metal phenoxybenzooxazole compounds


embedded image


WO2005089025








embedded image


WO2006132173








embedded image


JP200511610





Spirofluorene- carbazole compounds


embedded image


JP2007254297








embedded image


JP2007254297





Indolocabazoles


embedded image


WO2007063796








embedded image


WO2007063754





5-member ring electron deficient heterocycles (e.g., triazole, oxadiazole)


embedded image


J. Appl. Phys. 90, 5048 (2001)








embedded image


WO2004107822





Tetraphenylene complexes


embedded image


US20050112407





Metal phenoxypyridine compounds


embedded image


WO2005030900





Metal coordination complexes (e.g., Zn, Al with N{circumflex over ( )}N ligands)


embedded image


US20040137268, US20040137267










Blue hosts









Arylcarbazoles


embedded image


Appl. Phys. Lett, 82, 2422 (2003)








embedded image


US20070190359





Dibenzothiophene/ Dibenzofuran- carbazole compounds


embedded image


WO2006114966, US20090167162








embedded image


US20090167162








embedded image


WO2009086028








embedded image


US20090030202, US20090017330








embedded image


US20100084966





Silicon aryl compounds


embedded image


US20050238919








embedded image


WO2009003898





Silicon/Germanium aryl compounds


embedded image


EP2034538A





Aryl benzoyl ester


embedded image


WO2006100298





Carbazole linked by non-conjugated groups


embedded image


US20040115476





Aza-carbazoles


embedded image


US20060121308





High triplet metal organometallic complex


embedded image


U.S. Pat. No. 7,154,114










Phosphorescent dopants


Red dopants









Heavy metal porphyrins (e.g., PtOEP)


embedded image


Nature 395, 151 (1998)





Iridium(III) organometallic complexes


embedded image


Appl. Phys. Lett. 78, 1622 (2001)








embedded image


US2006835469








embedded image


US2006835469








embedded image


US20060202194








embedded image


US20060202194








embedded image


US20070087321








embedded image


US20080261076 US20100090591








embedded image


US20070087321








embedded image


Adv. Mater. 19, 739 (2007)








embedded image


WO2009100991








embedded image


WO2008101842








embedded image


U.S. Pat. No. 7,232,618





Platinum(II) organometallic complexes


embedded image


WO2003040257








embedded image


US20070103060





Osminum(III) complexes


embedded image


Chem. Mater. 17, 3532 (2005)





Ruthenium(II) complexes


embedded image


Adv. Mater. 17, 1059 (2005)





Rhenium (I), (II), and (III) complexes


embedded image


US20050244673










Green dopants









Iridium(III) organometallic complexes


embedded image


Inorg. Chem. 40, 1704 (2001)








embedded image


US20020034656








embedded image


U.S. Pat. No. 7,332,232








embedded image


US20090108737








embedded image


WO2010028151








embedded image


EP1841834B








embedded image


US20060127696








embedded image


US20090039776








embedded image


U.S. Pat. No. 6,921,915








embedded image


US20100244004








embedded image


U.S. Pat. No. 6,687,266








embedded image


Chem. Mater. 16, 2480 (2004)








embedded image


US20070190359








embedded image


US 20060008670 JP2007123392








embedded image


WO2010086089, WO2011044988








embedded image


Adv. Mater. 16, 2003 (2004)








embedded image


Angew. Chem. Int. Ed. 2006, 45, 7800








embedded image


WO2009050290








embedded image


US20090165846








embedded image


US20080015355








embedded image


US20010015432








embedded image


US20100295032





Monomer for polymeric metal organometallic compounds


embedded image


U.S. Pat. No. 7,250,226, U.S. Pat. No. 7,396,598





Pt(II) organometallic complexes, including polydentated ligands


embedded image


Appl. Phys. Lett. 86, 153505 (2005)








embedded image


Appl. Phys. Lett. 86, 153505 (2005)








embedded image


Chem. Lett. 34, 592 (2005)








embedded image


WO2002015645








embedded image


US20060263635








embedded image


US20060182992 US20070103060





Cu complexes


embedded image


WO2009000673








embedded image


US20070111026





Gold complexes


embedded image


Chem. Commun. 2906 (2005)





Rhenium(III) complexes


embedded image


Inorg. Chem. 42, 1248 (2003)





Osmium(II) complexes


embedded image


U.S. Pat. No. 7,279,704





Deuterated organometallic complexes


embedded image


US20030138657





Organometallic complexes with two or more metal centers


embedded image


US20030152802








embedded image


U.S. Pat. No. 7,090,928










Blue dopants









Iridium(III) organometallic complexes


embedded image


WO2002002714








embedded image


WO2006009024








embedded image


US20060251923 US20110057559 US20110204333








embedded image


U.S. Pat. No. 7,393,599, WO2006056418, US20050260441, WO2005019373








embedded image


U.S. Pat. No. 7,534,505








embedded image


WO2011051404








embedded image


U.S. Pat. No. 7,445,855








embedded image


US20070190359, US20080297033 US20100148663








embedded image


U.S. Pat. No. 7,338,722








embedded image


US20020134984








embedded image


Angew. Chem. Int. Ed. 47, 1 (2008)








embedded image


Chem. Mater. 18, 5119 (2006)








embedded image


Inorg. Chem. 46, 4308 (2007)








embedded image


WO2005123873








embedded image


WO2005123873








embedded image


WO2007004380








embedded image


WO2006082742





Osmium(II) complexes


embedded image


U.S. Pat. No. 7,279,704








embedded image


Organometallics 23, 3745 (2004)





Gold complexes


embedded image


Appl. Phys. Lett. 74, 1361 (1999)





Platinum(II) complexes


embedded image


WO2006098120, WO2006103874





Pt tetradentate complexes with at least one metal-carbene bond


embedded image


U.S. Pat. No. 7,655,323










Exciton/hole blocking layer materials









Bathocuprine compounds (e.g., BCP, BPhen)


embedded image


Appl. Phys. Lett. 75, 4 (1999)








embedded image


Appl. Phys. Lett. 79, 449 (2001)





Metal 8-hydroxyquinolates (e.g., BAlq)


embedded image


Appl. Phys. Lett. 81, 162 (2002)





5-member ring electron deficient heterocycles such as triazole, oxadiazole, imidazole, benzoimidazole


embedded image


Appl. Phys. Lett. 81, 162 (2002)





Triphenylene compounds


embedded image


US20050025993





Fluorinated aromatic compounds


embedded image


Appl. Phys. Lett. 79, 156 (2001)





Phenothiazine-S- oxide


embedded image


WO2008132085





Silylated five- membered nitrogen, oxygen, sulfur or phosphorus dibenzoheterocycles


embedded image


WO2010079051





Aza-carbazole


embedded image


US20060121308










Electron transporting materials









Anthracene- benzoimidazole compounds


embedded image


WO2003060956








embedded image


US20090179554





Aza triphenylene derivatives


embedded image


US20090115316





Anthracene- benzothiazole compounds


embedded image


Appl. Phys. Lett. 89, 063504 (2006)





Metal 8-hydroxyquinolates (e.g., Alq3, Zrq4)


embedded image


Appl. Phys. Lett. 51, 913 (1987) U.S. Pat. No. 7,230,107





Metal hydroxybenoquinolates


embedded image


Chem. Lett. 5, 905 (1993)





Bathocuprine compounds such as BCP, BPhen, etc


embedded image


Appl. Phys. Lett. 91, 263503 (2007)








embedded image


Appl. Phys. Lett. 79, 449 (2001)





5-member ring electron deficient heterocycles (e.g., triazole, oxadiazole, imidazole, benzoimidazole)


embedded image


Appl. Phys. Lett. 74, 865 (1999)








embedded image


Appl. Phys. Lett. 55, 1489 (1989)








embedded image


Jpn. J. Apply. Phys. 32, L917 (1993)





Silole compounds


embedded image


Org. Electron. 4, 113 (2003)





Arylborane compounds


embedded image


J. Am. Chem. Soc. 120, 9714 (1998)





Fluorinated aromatic compounds


embedded image


J. Am. Chem. Soc. 122, 1832 (2000)





Fullerene (e.g., C60)


embedded image


US20090101870





Triazine complexes


embedded image


US20040036077





Zn (N{circumflex over ( )}N) complexes


embedded image


U.S. Pat. No. 6,528,187









EXAMPLES
Example 1—Computational Examples

DFT calculations were performed for certain example compounds and comparative compounds. The example compounds and comparative compounds are shown on the following page. In certain models, a hot, Host 1, was used, which is also shown.




embedded image


embedded image


embedded image


embedded image


embedded image


Geometry optimization calculations were performed within the Gaussian 09 software package using the B3LYP hybrid functional and CEP-31g effective core potential basis set. Complexes were optimized as both ground state singlets and triplets. Three bonds strengths of interest were examined: N-aryl, N-phenyl, and N-Phenyl2, the identities of which are shown in Structure A atop the following page.




embedded image



Bond strength calculations were executed at the same level of theory by two approaches which were dependent on either (a) creating two fragments or (b) breaking a bond that does not cause fragmentation.


Fragmentation of the phenyl group from the bridging nitrogen (Nphenyl) results in the transition metal fragment in a doublet spin state and the phenyl group also in a doublet spin state. The complete fragmentation is only observed for Comparative Examples 4-6, where the N-phenyl bond is not tethered. For these complexes, the Nphenyl fragment can be completely removed whereas for Compound 1-4, the phenyl fragment remains bound to the complex on one or both sides. For complexes that do not fragment the phenyl bonded to the bridging nitrogen both singlet→singlet and triplet→triplet spin states bond strength energies were calculated. The results are shown below in TABLE 2.















TABLE 2







N-Phenyl
N-Aryl
N-Phenyl-2






Bond
Bond
Bond

Device




Strength,
Strength,
Strength,

Lifetime



Calc
singlet/
singlet/
singlet/
Weakest
(relative to



T1
triplet
triplet
triplet
bond
comparative


Compound
(nm)
(kcal/mol)
(kcal/mol)
(kcal/mol)
(kcal/mol)
example 1)





















Comparative
467
66.82/8.02 
74.08/15.28
85.89/27.09
8.02
1


Example 1


Comparative
502
67.69/13.35
77.15/22.81

13.35
10


Example 2


Comparative
508
68.79/15.32
n/a

15.32
100


Example 3


Comparative
467
66.92/8.17 
74.15/15.40
84.98/26.23
8.17


Example 4


Comparative
475
66.35/10.99
75.29/19.93
85.41/30.06
10.99


Example 5


Comparative
467
66.40/7.82 
74.21/15.63
86.00/27.42
7.82


Example 6


Comparative

67.86/25.67


25.67


Example 7


Comparative

69.19/15.01


15.01


Example 8


Comparative

67.33/14.26


14.26


Example 9


Compound 1
475
70.31/11.52
75.84/17.05
75.73/16.95
11.52


Compound 2
464
73.10/12.36
75.57/14.83
81.82/21.08
12.36


Compound 3
466
62.84/5.22*
71.73/14.10
83.04/25.42
14.10


Compound 4
464
78.26/17.70
76.56/16.00
83.92/23.36
16.00


Compound 8

73.59/29.07


29.07


Compound 56

75.16/21.18


21.18


Compound 57

76.07/22.91


22.91


Compound 58

77.67/24.97


24.97









As shown in TABLE 2, calculations indicate that linking the phenyl in the N-phenyl position to the phenyl of the phenlyimidazole ligand increases the N-phenyl bond strength. In the triplet state, Comparative Example 1 has an N-phenyl bond strength of 8.02 kcal/mole. Comparative Examples 4 and 6, without tethering substitutions are found to have similar N-phenyl bond strength compared to Comparative Example 1. Compound 2 is shown to have a stronger N-phenyl bond of 10.99 kcal/mol, however, the triplet energy of 475 nm is lower than Comparative Example 1. Tethered examples, Compounds 1-4 are found to have stronger N-phenyl bonds while in several cases retaining the desirable high triplet energy. A special case is found for Compound 3, which is tethered by geminal dimethyl groups on both sides. As shown in the table, designated by “*”, these substitutions are calculated to have a large impact on the N-phenyl bond strength. Linking the phenyl group to the complex on both sides prevents the phenyl from twisting or moving out of the bonding position. Optimization results in a distorted geometry of Compound 3, such that the phenyl is not directly lined up with the nitrogen and the N-phenyl bond. The distortion results in a relatively small calculated energy difference of 5.22 kcal/mol for the N-phenyl bond strength of Compound 3. However, the N-phenyl bond is reformed, so the small difference in energy is related to the slight geometry difference, not a broken bond. The calculated geometric distortion for Compound 3 is shown in FIG. 7. Thus, tethering (or bridging) the phenyl group on both sides retains the N-phenyl bond and shifts the lowest bond strength to the N-aryl bond. In addition the other structures, Compound 1, 2 and 4, are found to have greater N-phenyl bond strengths compared to Comparative Example 1.


Calculating the Naryl bond strengths was done by removing the dimethylphenyl group and separately calculating the energies of the doublet complex and dimethylphenyl. There are no major differences in the N-aryl bond strengths besides the differing ground state triplet energies between the complexes.


Finally, calculations were performed on the N-phenyl-2 bond in which the bridging N atom is detached from the phenyl of the phenylimidazole ligand. This bond is calculated to be the strongest bond of the three investigated except for complex Compound 1. The N-phenyl-2 bond strength is calculated to be a mere 0.1 kcal/mol weaker than the N-aryl bond for complex Compound 1. In all cases, the N-phenyl-2 bond is never calculated to be the weakest bond of the complex. This suggests that the breaking the N-phenyl-2 bond is not a significant source of decomposition. In addition, Compound 8, 56, 57, and 58 further demonstrate the versatility of this approach. In each case the N-aryl bond strength is calculated to be greater than the corresponding untethered comparative example, Comparative Example 7, 8 and 9.


Example 2—MALDI-TOF Fragmentation

The relative instability of the N—C ring bond is demonstrated experimentally by excited state fragmentation patterns observed in a MALDI mass spectrometer. Host 1 and Comparative Examples 1-3 at an approximate 20 wt % ratio were dissolved in dichloromethane and spot cast on an Applied Biosystems Voyager DE-STR MALDI sample target plate. The samples were analyzed in the positive mode. FIGS. 4-6 show that there is a major fragment that results from the loss of the N-phenyl ring, i.e. N—C ring bond breakage. In each case, it is found that the broken N—C bond is an abundant fragment associated with the dopant.


Without being bound to any theory, it is believed that linking or tethering (or bridging) the C-Ring back to the complex will result in an improvement in stability particularly for phosphorescent metal complexes with bridging aryl amine substitutions.


It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.

Claims
  • 1. A compound which has a structure of Formula (VI)
  • 2. The compound of claim 1, wherein G4 is selected from S, SiR20R20a, and NR20, and G5 is selected from S, SiR21R21a, and NR21.
  • 3. The compound of claim 1, wherein G5 is selected from the group consisting of O, S, and SiR21R21a, and NR21.
  • 4. The compound of claim 1, wherein G5 is NR21.
  • 5. The compound of claim 4, wherein R21 is combined with one R2 to form a ring system, which can be further substituted.
  • 6. The compound of claim 4, wherein R21 is combined with one R17 to form a ring system, which can be further substituted.
  • 7. The compound of claim 4, wherein R21 is aryl and is bonded to the ring substituted by R2 by a direct bond to form a ring system, which can be further substituted.
  • 8. The compound of claim 7, wherein R21 is phenyl.
  • 9. The compound of claim 4, wherein R21 is aryl and is bonded to A7 by a direct bond to form a ring system, which can be further substituted.
  • 10. The compound of claim 1, wherein Z8 and Z9 are nitrogen.
  • 11. The compound of claim 10, wherein A7 is a 5-membered ring and A8 is a 6-membered ring.
  • 12. The compound of claim 11, wherein A9 is phenyl.
  • 13. The compound of claim 10, wherein A7 is a 6-membered ring and A8 is a 6-membered ring.
  • 14. A first device comprising a first organic light emitting device, which further comprises: an anode;a cathode; andan organic layer disposed between the anode and the cathode, which comprises a compound having a structure of Formula (VI)
  • 15. The first device of claim 14, wherein the first device is a consumer product, an organic light-emitting device, or a lighting panel.
  • 16. The first device of claim 14, wherein the organic layer is an emissive layer and the compound is an emissive dopant.
  • 17. The first device of claim 14, wherein the organic layer is an emissive layer and the compound is a non-emissive dopant.
  • 18. The first device of claim 14, wherein the organic layer further comprises a host, wherein the host comprises a compound selected from the group consisting of: carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
  • 19. The first device of claim 14, wherein the organic layer further comprises a host, wherein the host is selected from the group consisting of:
  • 20. The first device of claim 14, wherein the organic layer further comprises a host, wherein the host comprises a metal complex.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a division of U.S. patent application Ser. No. 15/067,536, filed Mar. 11, 2016, which is a division of U.S. patent application Ser. No. 13/787,169, filed Mar. 6, 2013, which claims priority to U.S. Provisional Application Ser. No. 61/705,400, filed Sep. 25, 2012, the entire contents of which are incorporated herein by reference.

US Referenced Citations (84)
Number Name Date Kind
4769292 Tang et al. Sep 1988 A
5061569 VanSlyke et al. Oct 1991 A
5247190 Friend et al. Sep 1993 A
5703436 Forrest et al. Dec 1997 A
5707745 Forrest et al. Jan 1998 A
5834893 Bulovic et al. Nov 1998 A
5844363 Gu et al. Dec 1998 A
6013982 Thompson et al. Jan 2000 A
6087196 Sturm et al. Jul 2000 A
6091195 Forrest et al. Jul 2000 A
6097147 Baldo et al. Aug 2000 A
6294398 Kim et al. Sep 2001 B1
6303238 Thompson et al. Oct 2001 B1
6337102 Forrest et al. Jan 2002 B1
6468819 Kim et al. Oct 2002 B1
6528187 Okada Mar 2003 B1
6687266 Ma et al. Feb 2004 B1
6835469 Kwong et al. Dec 2004 B2
6893743 Sato et al. May 2005 B2
6921915 Takiguchi et al. Jul 2005 B2
7087321 Kwong et al. Aug 2006 B2
7090928 Thompson et al. Aug 2006 B2
7154114 Brooks et al. Dec 2006 B2
7250226 Tokito et al. Jul 2007 B2
7279704 Walters et al. Oct 2007 B2
7332232 Ma et al. Feb 2008 B2
7338722 Thompson et al. Mar 2008 B2
7393599 Thompson et al. Jul 2008 B2
7396598 Takeuchi et al. Jul 2008 B2
7431968 Shtein et al. Oct 2008 B1
7442797 Itoh et al. Oct 2008 B2
7445855 Mackenzie et al. Nov 2008 B2
7534505 Lin et al. May 2009 B2
9238668 Li et al. Jan 2016 B2
20020034656 Thompson et al. Mar 2002 A1
20020134984 Igarashi Sep 2002 A1
20020158242 Son et al. Oct 2002 A1
20030138657 Li et al. Jul 2003 A1
20030152802 Tsuboyama et al. Aug 2003 A1
20030162053 Marks et al. Aug 2003 A1
20030175553 Thompson et al. Sep 2003 A1
20030230980 Forrest et al. Dec 2003 A1
20040036077 Ise Feb 2004 A1
20040137267 Igarashi et al. Jul 2004 A1
20040137268 Igarashi et al. Jul 2004 A1
20040174116 Lu et al. Sep 2004 A1
20050006625 Seo Jan 2005 A1
20050025993 Thompson et al. Feb 2005 A1
20050112407 Ogasawara et al. May 2005 A1
20050238919 Ogasawara Oct 2005 A1
20050244673 Satoh et al. Nov 2005 A1
20050260441 Thompson et al. Nov 2005 A1
20050260449 Walters et al. Nov 2005 A1
20060008670 Lin et al. Jan 2006 A1
20060202194 Jeong et al. Sep 2006 A1
20060240279 Adamovich et al. Oct 2006 A1
20060251923 Lin et al. Nov 2006 A1
20060263635 Ise Nov 2006 A1
20060280965 Kwong et al. Dec 2006 A1
20070059551 Yamazaki Mar 2007 A1
20070190359 Knowles et al. Aug 2007 A1
20070278938 Yabunouchi et al. Dec 2007 A1
20080015355 Schafer et al. Jan 2008 A1
20080018221 Egen et al. Jan 2008 A1
20080036373 Itoh et al. Feb 2008 A1
20080106190 Yabunouchi et al. May 2008 A1
20080124572 Mizuki et al. May 2008 A1
20080220265 Xia et al. Sep 2008 A1
20080297033 Knowles et al. Dec 2008 A1
20090008605 Kawamura et al. Jan 2009 A1
20090009065 Nishimura et al. Jan 2009 A1
20090017330 Iwakuma et al. Jan 2009 A1
20090030202 Iwakuma et al. Jan 2009 A1
20090039776 Yamada et al. Feb 2009 A1
20090045730 Nishimura et al. Feb 2009 A1
20090045731 Nishimura et al. Feb 2009 A1
20090101870 Prakash et al. Apr 2009 A1
20090108737 Kwong et al. Apr 2009 A1
20090115316 Zheng et al. May 2009 A1
20090165846 Johannes et al. Jul 2009 A1
20090167162 Lin et al. Jul 2009 A1
20090179554 Kuma et al. Jul 2009 A1
20120302753 Li Nov 2012 A1
20140091265 Stoessel et al. Apr 2014 A1
Foreign Referenced Citations (51)
Number Date Country
0650955 May 1995 EP
1725079 Nov 2006 EP
2034538 Mar 2009 EP
200511610 Jan 2005 JP
2007123392 May 2007 JP
2007254297 Oct 2007 JP
2008074939 Apr 2008 JP
10-2006-0115371 Nov 2006 KR
10-1897044 Oct 2018 KR
10-1972184 Apr 2019 KR
0139234 May 2001 WO
0202714 Jan 2002 WO
02015654 Feb 2002 WO
03040257 May 2003 WO
03060956 Jul 2003 WO
2004093207 Oct 2004 WO
2004107822 Dec 2004 WO
2005014551 Feb 2005 WO
2005019373 Mar 2005 WO
2005030900 Apr 2005 WO
2005089025 Sep 2005 WO
2005123873 Dec 2005 WO
2006009024 Jan 2006 WO
2006056418 Jun 2006 WO
2006072002 Jul 2006 WO
2006082742 Aug 2006 WO
2006098120 Sep 2006 WO
2006100298 Sep 2006 WO
2006103874 Oct 2006 WO
2006114966 Nov 2006 WO
2006132173 Dec 2006 WO
2007002683 Jan 2007 WO
2007004380 Jan 2007 WO
2007063754 Jun 2007 WO
2007063796 Jun 2007 WO
2008056746 May 2008 WO
2008101842 Aug 2008 WO
2008132085 Nov 2008 WO
2009000673 Dec 2008 WO
2009003898 Jan 2009 WO
2009008311 Jan 2009 WO
2009018009 Feb 2009 WO
2009021126 Feb 2009 WO
2009050290 Apr 2009 WO
2009062578 May 2009 WO
2009063833 May 2009 WO
2009066778 May 2009 WO
2009066779 May 2009 WO
2009086028 Jul 2009 WO
2009100991 Aug 2009 WO
2012163471 Dec 2012 WO
Non-Patent Literature Citations (48)
Entry
U.S. Appl. No. 61/490,111, filed May 26, 2011.
Korean Office Action dated Jul. 18, 2019 for corresponding Korean Patent Application No. 10-2013-0113223.
Adachi, Chihaya et al., “Organic Electroluminescent Device Having a Hole Conductor as an Emitting Layer,” Appl. Phys. Lett., 55(15): 1489-1491 (1989).
Adachi, Chihaya et al., “Nearly 100% Internal Phosphorescence Efficiency in an Organic Light Emitting Device,” J. Appl. Phys., 90(10): 5048-5051 (2001).
Adachi, Chihaya et al., “High-Efficiency Red Electrophosphorescence Devices,” Appl. Phys. Lett., 78(11)1622-1624 (2001).
Aonuma, Masaki et al., “Material Design of Hole Transport Materials Capable of Thick-Film Formation in Organic Light Emitting Diodes,” Appl. Phys. Lett., 90, Apr. 30, 2007, 183503-1-183503-3.
Baldo et al., Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices, Nature, vol. 395, 151-154, (1998).
Baldo et al., Very high-efficiency green organic light-emitting devices based on electrophosphorescence, Appl. Phys. Lett., vol. 75, No. 1, 4-6 (1999).
Gao, Zhiqiang et al., “Bright-Blue Electroluminescence From a Silyl-Substituted ter-(phenylene-vinylene) derivative,” Appl. Phys. Lett., 74(6): 865-867 (1999).
Guo, Tzung-Fang et al., “Highly Efficient Electrophosphorescent Polymer Light-Emitting Devices,” Organic Electronics, 1: 15-20 (2000).
Hamada, Yuji et al., “High Luminance in Organic Electroluminescent Devices with Bis(10-hydroxybenzo[h]quinolinato) beryllium as an Emitter,” Chem. Lett., 905-906 (1993).
Holmes, R.J. et al., “Blue Organic Electrophosphorescence Using Exothermic Host-Guest Energy Transfer,” Appl. Phys. Lett., 82(15):2422-2424 (2003).
Hu, Nan-Xing et al., “Novel High Tg Hole-Transport Molecules Based on Indolo[3,2-b]carbazoles for Organic Light-Emitting Devices,” Synthetic Metals, 111-112:421-424 (2000).
Huang, Jinsong et al., “Highly Efficient Red-Emission Polymer Phosphorescent Light-Emitting Diodes Based on Two Novel Tris(1-phenylisoquinolinato-C2,N)iridium(III) Derivatives,” Adv. Mater., 19:739-743 (2007).
Huang, Wei-Sheng et al., “Highly Phosphorescent Bis-Cyclometalated Iridium Complexes Containing Benzoimidazole-Based Ligands,” Chem. Mater., 16(12):2480-2488 (2004).
Hung, L.S. et al., “Anode Modification in Organic Light-Emitting Diodes by Low-Frequency Plasma Polymerization of CHF3,” Appl. Phys. Lett., 78(5):673-675 (2001).
Ikai, Masamichi et al., “Highly Efficient Phosphorescence From Organic Light-Emitting Devices with an Exciton-Block Layer,” Appl. Phys. Lett., 79(2):156-158 (2001).
Ikeda, Hisao et al., “P-185 Low-Drive-Voltage OLEDs with a Buffer Layer Having Molybdenum Oxide,” SID Symposium Digest, 37:923-926 (2006).
Inada, Hiroshi and Shirota, Yasuhiko, “1,3,5-Tris[4-(diphenylamino)phenyl]benzene and its Methylsubstituted Derivatives as a Novel Class of Amorphous Molecular Materials,” J. Mater. Chem., 3(3):319-320 (1993).
Kanno, Hiroshi et al., “Highly Efficient and Stable Red Phosphorescent Organic Light-Emitting Device Using bis[2-(2-benzothiazoyl)phenolato]zinc(II) as host material,” Appl. Phys. Lett., 90:123509-1-123509-3 (2007).
Kido, Junji et al., 1,2,4-Triazole Derivative as an Electron Transport Layer in Organic Electroluminescent Devices, Jpn. J. Appl. Phys., 32:L917-L920 (1993).
Kuwabara, Yoshiyuki et al., “Thermally Stable Multilayered Organic Electroluminescent Devices Using Novel Starburst Molecules, 4,4′,4″-Tri(N-carbazolyl)triphenylamine (TCTA) and 4,4′,4″-Tris(3-methylphenylphenyl-amino) triphenylamine (m-MTDATA), as Hole-Transport Materials,” Adv. Mater., 6(9):677-679 (1994).
Kwong, Raymond C. et al., “High Operational Stability of Electrophosphorescent Devices,” Appl. Phys. Lett., 81(1)162-164 (2002).
Lamansky, Sergey et al., “Synthesis and Characterization of Phosphorescent Cyclometalated Iridium Complexes,” Inorg. Chem., 40(7):1704-1711 (2001).
Lee, Chang-Lyoul et al., “Polymer Phosphorescent Light-Emitting Devices Doped with Tris(2-phenylpyridine) Iridium as a Triplet Emitter,” Appl. Phys. Lett., 77(15):2280-2282 (2000).
O, Shih-Chun et al., “Blue Phosphorescence from Iridium(III) Complexes at Room Temperature,” Chem. Mater., 18(21)5119-5129 (2006).
Ma, Yuguang et al., “Triplet Luminescent Dinuclear-Gold(I) Complex-Based Light-Emitting Diodes with Low Turn-On voltage,” Appl. Phys. Lett., 74(10):1361-1363 (1999).
Mi, Bao-Xiu et al., “Thermally Stable Hole-Transporting Material for Organic Light-Emitting Diode an Isoindole Derivative,” Chem. Mater., 15(16):3148-3151 (2003).
Nishida, Jun-ichi et al., “Preparation, Characterization, and Electroluminescence Characteristics of α-Diimine-type Platinum(II) Complexes with Perfluorinated Phenyl Groups as Ligands,” Chem. Lett., 34(4): 592-593 (2005).
Niu, Yu-Hua et al., “Highly Efficient Electrophosphorescent Devices with Saturated Red Emission from a Neutral Osmium Complex,” Chem. Mater., 17(13):3532-3536 (2005).
Noda, Tetsuya and Shirota, Yasuhiko, “5,5′-Bis(dimesitylboryl)-2,2′-bithiophene and 5,5″-Bis(dimesitylboryl)-2,2′5′,2″-terthiophene as a Novel Family of Electron-Transporting Amorphous Molecular Materials,” J. Am. Chem. Soc., 120 (37):9714-9715 (1998).
Okumoto, Kenji et al., “Green Fluorescent Organic Light-Emitting Device with External Quantum Efficiency of Nearly 10%,” Appl. Phys. Lett., 89:063504-1-063504-3 (2006).
Palilis, Leonidas C., “High Efficiency Molecular Organic Light-Emitting Diodes Based On Silole Derivatives And Their Exciplexes,” Organic Electronics, 4:113-121 (2003).
Paulose, Betty Marie Jennifer S. et al., “First Examples of Alkenyl Pyridines as Organic Ligands for Phosphorescent Iridium Complexes,” Adv. Mater., 16(22):2003-2007 (2004).
Ranjan, Sudhir et al., “Realizing Green Phosphorescent Light-Emitting Materials from Rhenium(I) Pyrazolato Diimine Complexes,” Inorg. Chem., 42(4):1248-1255 (2003).
Sakamoto, Youichi et al., “Synthesis, Characterization, and Electron-Transport Property of Perfluorinated Phenylene Dendrimers,” J. Am. Chem. Soc., 122(8):1832-1833 (2000).
Salbeck, J. et al., “Low Molecular Organic Glasses for Blue Electroluminescence,” Synthetic Metals, 91: 209-215 (1997).
Shirota, Yasuhiko et al., “Starburst Molecules Based on pi-Electron Systems as Materials for Organic Electroluminescent Devices,” Journal of Luminescence, 72-74:985-991 (1997).
Sotoyama, Wataru et al., “Efficient Organic Light-Emitting Diodes with Phosphorescent Platinum Complexes Containing N^C^N-Coordinating Tridentate Ligand,” Appl. Phys. Lett., 86:153505-1-153505-3 (2005).
Sun, Yiru and Forrest, Stephen R., “High-Efficiency White Organic Light Emitting Devices with Three Separate Phosphorescent Emission Layers,” Appl. Phys. Lett., 91:263503-1-263503-3 (2007).
T. Östergård et al., “Langmuir-Blodgett Light-Emitting Diodes Of Poly(3-Hexylthiophene) Electro-Optical Characteristics Related to Structure,” Synthetic Metals, 88:171-177 (1997).
Takizawa, Shin-ya et al., “Phosphorescent Iridium Complexes Based on 2-Phenylimidazo[1,2-α]pyridine Ligands Tuning of Emission Color toward the Blue Region and Application to Polymer Light-Emitting Devices,” Inorg. Chem., 46(10):4308-4319 (2007).
Tang, C.W. and VanSlyke, S.A., “Organic Electroluminescent Diodes,” Appl. Phys. Lett., 51(12):913-915 (1987).
Tung, Yung-Liang et al., “Organic Light-Emitting Diodes Based on Charge-Neutral Ru II PHosphorescent Emitters,” Adv. Mater., 17(8)1059-1064 (2005).
Van Slyke, S. A. et al., “Organic Electroluminescent Devices with Improved Stability,” Appl. Phys. Lett., 69(15):2160-2162 (1996).
Wang, Y. et al., “Highly Efficient Electroluminescent Materials Based on Fluorinated Organometallic Iridium Compounds,” Appl. Phys. Lett., 79(4):449-451 (2001).
Wong, Keith Man-Chung et al., A Novel Class of Phosphorescent Gold(III) Alkynyl-Based Organic Light-Emitting Devices with Tunable Colour, Chem. Commun., 2906-2908 (2005).
Wong, Wai-Yeung, “Multifunctional Iridium Complexes Based on Carbazole Modules as Highly Efficient Electrophosphors,” Angew. Chem. Int. Ed., 45:7800-7803 (2006).
Related Publications (1)
Number Date Country
20190326528 A1 Oct 2019 US
Provisional Applications (1)
Number Date Country
61705400 Sep 2012 US
Divisions (2)
Number Date Country
Parent 15067536 Mar 2016 US
Child 16456894 US
Parent 13787169 Mar 2013 US
Child 15067536 US